Literature DB >> 18687901

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.

Clement A Gautier1, Tohru Kitada, Jie Shen.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder thought to be associated with mitochondrial dysfunction. Loss of function mutations in the putative mitochondrial protein PINK1 (PTEN-induced kinase 1) have been linked to familial forms of PD, but the relation of PINK1 to mammalian mitochondrial function remains unclear. Here, we report that germline deletion of the PINK1 gene in mice significantly impairs mitochondrial functions. Quantitative electron microscopic studies of the striatum in PINK1(-/-) mice at 3-4 and 24 months revealed no gross changes in the ultrastructure or the total number of mitochondria, although the number of larger mitochondria is selectively increased. Functional assays showed impaired mitochondrial respiration in the striatum but not in the cerebral cortex at 3-4 months of age, suggesting specificity of this defect for dopaminergic circuitry. Aconitase activity associated with the Krebs cycle is also reduced in the striatum of PINK1(-/-) mice. Interestingly, mitochondrial respiration activities in the cerebral cortex are decreased in PINK1(-/-) mice at 2 years compared with control mice, indicating that aging can exacerbate mitochondrial dysfunction in these mice. Furthermore, mitochondrial respiration defects can be induced in the cerebral cortex of PINK1(-/-) mice by cellular stress, such as exposure to H(2)O(2) or mild heat shock. Together, our findings demonstrate that mammalian PINK1 is important for mitochondrial function and provides critical protection against both intrinsic and environmental stress, suggesting a pathogenic mechanism by which loss of PINK1 may lead to nigrostriatal degeneration in PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687901      PMCID: PMC2516271          DOI: 10.1073/pnas.0802076105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

Authors:  Paula M Keeney; Jing Xie; Roderick A Capaldi; James P Bennett
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

2.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

3.  Origin and functional consequences of the complex I defect in Parkinson's disease.

Authors:  R H Swerdlow; J K Parks; S W Miller; J B Tuttle; P A Trimmer; J P Sheehan; J P Bennett; R E Davis; W D Parker
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

4.  Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

Authors:  Alexandra Beilina; Marcel Van Der Brug; Rili Ahmad; Sashi Kesavapany; David W Miller; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

5.  Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.

Authors:  Martin R Gluck; Gail D Zeevalk
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

6.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.

Authors:  R Benecke; P Strümper; H Weiss
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

7.  Superoxide sensitivity of the Escherichia coli aconitase.

Authors:  P R Gardner; I Fridovich
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

8.  Parkinson's disease: a case-control study of occupational and environmental risk factors.

Authors:  C Hertzman; M Wiens; D Bowering; B Snow; D Calne
Journal:  Am J Ind Med       Date:  1990       Impact factor: 2.214

9.  Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease.

Authors:  R H Haas; F Nasirian; K Nakano; D Ward; M Pay; R Hill; C W Shults
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422

10.  Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

Authors:  Laura Silvestri; Viviana Caputo; Emanuele Bellacchio; Luigia Atorino; Bruno Dallapiccola; Enza Maria Valente; Giorgio Casari
Journal:  Hum Mol Genet       Date:  2005-10-05       Impact factor: 6.150

View more
  292 in total

1.  Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.

Authors:  Matthew W Bishop; Subhojit Chakraborty; Gillian A C Matthews; Antonios Dougalis; Nicholas W Wood; Richard Festenstein; Mark A Ungless
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

2.  Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.

Authors:  R K Dagda; A M Gusdon; I Pien; S Strack; S Green; C Li; B Van Houten; S J Cherra; C T Chu
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

3.  PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

Authors:  Xinnan Wang; Dominic Winter; Ghazaleh Ashrafi; Julia Schlehe; Yao Liang Wong; Dennis Selkoe; Sarah Rice; Judith Steen; Matthew J LaVoie; Thomas L Schwarz
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

4.  Mitochondrial aconitase knockdown attenuates paraquat-induced dopaminergic cell death via decreased cellular metabolism and release of iron and H₂O₂.

Authors:  David Cantu; Ruth E Fulton; Derek A Drechsel; Manisha Patel
Journal:  J Neurochem       Date:  2011-05-19       Impact factor: 5.372

Review 5.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

6.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

Review 7.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

8.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

10.  Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.

Authors:  G Martella; P Platania; D Vita; G Sciamanna; D Cuomo; A Tassone; A Tscherter; T Kitada; P Bonsi; J Shen; A Pisani
Journal:  Exp Neurol       Date:  2008-11-21       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.